# A Study to Evaluate the Combination of Valsartan and Amlodipine in Hypertensive Patients Not Controlled on Monotherapy

> **NCT00327145** · PHASE3 · COMPLETED · sponsor: **Novartis** · enrollment: 894 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** valsartan
- **DRUG:** hydrochlorothiazide
- **DRUG:** amlodipine

## Key facts

- **NCT ID:** NCT00327145
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** 2007-01
- **Final completion:** 2007-01
- **Target enrollment:** 894 (ACTUAL)
- **Last updated:** 2016-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00327145

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00327145, "A Study to Evaluate the Combination of Valsartan and Amlodipine in Hypertensive Patients Not Controlled on Monotherapy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00327145. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*